We are live on ! Find out more
SAMH

Shanda Asset Management Holdings Portfolio holdings

AUM $1.85B
1-Year Est. Return 36.09%
This Fund
S&P 500
This Quarter Est. Return
+18.41%
1 Year Est. Return
+36.09%
3 Year Est. Return
+114.94%
5 Year Est. Return
-33.67%
10 Year Est. Return
-25.97%
AUM
$618M
AUM Growth
+$83.5M
Cap. Flow
-$7.38M
Cap. Flow %
-1.19%
Top 10 Hldgs %
90.11%
Holding
58
New
8
Increased
7
Reduced
14
Closed
7

Top Buys

Rank Stock Value
1
CLDR
Cloudera, Inc.
CLDR
+$19M
2
HTGC icon
Hercules Capital
HTGC
+$3.76M
3
DPZ icon
Domino's
DPZ
+$3.66M
4
URI icon
United Rentals
URI
+$1.78M
5
BIIB icon
Biogen
BIIB
+$1.57M

Top Sells

Rank Stock Value
1
CAR icon
Avis
CAR
+$11.9M
2
BLK icon
Blackrock
BLK
+$5.13M
3
KKR icon
KKR & Co
KKR
+$4.51M
4
HDP
Hortonworks, Inc.
HDP
+$4.48M
5
CRI icon
Carter's
CRI
+$3.87M

Sector Composition

Rank Sector Weight
1 Financials 61.84%
2 Healthcare 19.6%
3 Technology 5.56%
4 Communication Services 4.84%
5 Consumer Discretionary 2.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
26
DELISTED
Instructure, Inc.
INST
$1.41M 0.23%
30,000
IQV icon
27
IQVIA
IQV
$39.3B
$1.33M 0.21%
9,224
BIIB icon
28
Biogen
BIIB
$30.7B
$1.18M 0.19%
+5,000
New +$1.57M
PTCT icon
29
PTC Therapeutics
PTCT
$6.12B
$1.14M 0.18%
30,332
TDOC icon
30
Teladoc Health
TDOC
$1.3B
$1.11M 0.18%
20,000
-15,800
-44% -$965K
SGMO
31
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.09M 0.18%
114,410
TVRD
32
Tvardi Therapeutics
TVRD
$23.4M
$1.08M 0.17%
1,527
CRI icon
33
Carter's
CRI
$1.47B
$1.01M 0.16%
10,000
-43,414
-81% -$3.87M
BECN
34
DELISTED
Beacon Roofing Supply, Inc.
BECN
$965K 0.16%
30,000
-35,240
-54% -$1.23M
ATVI
35
DELISTED
Activision Blizzard
ATVI
$911K 0.15%
+20,000
New +$904K
JWN
36
DELISTED
Nordstrom
JWN
$888K 0.14%
+20,000
New +$912K
NBIX icon
37
Neurocrine Biosciences
NBIX
$16.6B
$881K 0.14%
10,000
ENB icon
38
Enbridge
ENB
$112B
$867K 0.14%
23,900
-47,800
-67% -$1.72M
NTLA icon
39
Intellia Therapeutics
NTLA
$1.67B
$831K 0.13%
48,657
VNDA icon
40
Vanda Pharmaceuticals
VNDA
$302M
$824K 0.13%
44,787
ZGNX
41
DELISTED
Zogenix, Inc.
ZGNX
$550K 0.09%
10,000
PRAH
42
DELISTED
PRA Health Sciences, Inc.
PRAH
$549K 0.09%
4,980
+2,000
+67% +$209K
UPWK icon
43
Upwork
UPWK
$1.19B
$479K 0.08%
+25,000
New +$512K
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$430K 0.07%
35,278
LH icon
45
Labcorp
LH
$25.9B
$355K 0.06%
2,698
-2,698
-50% -$332K
SUPN icon
46
Supernus Pharmaceuticals
SUPN
$2.77B
$350K 0.06%
10,000
ACOR
47
DELISTED
Acorda Therapeutics
ACOR
$345K 0.06%
216
ICLR icon
48
Icon
ICLR
$12.7B
$341K 0.06%
2,499
CRL icon
49
Charles River Laboratories
CRL
$12.8B
$321K 0.05%
2,207
AXSM icon
50
Axsome Therapeutics
AXSM
$10.9B
$284K 0.05%
19,958

Similar funds

Shanda Asset Management Holdings's Q1 2019 Portfolio in Review

As of Q1 2019, Shanda Asset Management Holdings held 58 positions worth $618M, up 16% from $535M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Shanda Asset Management Holdings's Q1 2019 filing shows 8 new, 7 increased, 14 reduced and 7 closed positions. Its largest new stake was Domino's: 14,081 shares worth $3.63M. The largest sale was Avis, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 62% of assets, down from 62% a quarter earlier, followed by Healthcare and Technology.

  • Shanda Asset Management Holdings's largest Q1 2019 buy was Domino's: 14,081 shares worth $3.63M.
  • Shanda Asset Management Holdings added most to Cloudera, Inc. in Q1 2019, an estimated $19M increase.
  • Shanda Asset Management Holdings's biggest Q1 2019 reduction was Blackrock, cutting an estimated $5.13M.
  • Shanda Asset Management Holdings fully exited Avis in Q1 2019, selling an estimated $11.9M.
  • Shanda Asset Management Holdings's ten largest holdings make up 90% of its $618M portfolio in Q1 2019.
  • Shanda Asset Management Holdings opened 8 new positions and closed 7 in Q1 2019.
  • Shanda Asset Management Holdings's portfolio value rose 16% quarter-over-quarter to $618M.

Based on Shanda Asset Management Holdings's 13F filing for Q1 2019, filed 15 May 2019.